The expression of the gene 2 sarcoplasmic/endoplasmic-reticulum Ca2l-pump isoforms (SERCA2a and SERCA2b) and of phospholamban was studied in pig smooth muscle of the stomach, longitudinal ileum, pulmonary artery and aorta. mRNA levels were determined using an RNAase protection assay. The SERCA2 isoforms and phospholamban were tested on Western blots with a panel of antibodies, some of which were isoform-specific. The pig smooth-muscle tissues all contained comparable SERCA2 mRNA levels, but these levels were 10-20-fold lower than SERCA2 mRNA levels in cardiac muscle. Of the SERCA2 mRNAs in smooth muscle, 72-81 % encoded the non-muscle isoform (SERCA2b), and Western blot analysis with isoform-specific antibodies confirmed that the SERCA2b isoform is the predominant endoplasmic-reticulum Ca2+ pump in smooth muscle. In contrast with SERCA2 mRNA levels, phospholamban mRNA levels varied by 12-fold between the different pig smooth-muscle tissues, with low and very low levels in the pig pulmonary artery and the pig aorta respectively. The differential expression of phospholamban was also confirmed on Western blots. The finding that the phospholamban content varied between the different smooth-muscle tissues whereas the SERCA2 expression remained rather constant indicates that, in pig smooth muscle, the expression of phospholamban is not coupled with that of SERCA2.
INTRODUCTION
In the past few years, a series of sarcoplasmic/endoplasmicreticulum (SR/ER) Ca2+-pump isoforms has been described [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] . Three different genes (SERCAI, SERCA2 and SERCA3; the nomenclature for the SR/ER Ca2+ pumps is that of Burk et al. [12] ) as well as alternative processing of the SERCAI and SERCA2 transcripts result in the expression of at least five different SR/ER Ca2+-pump isoforms. Molecular cloning of the smooth-muscle ER Ca2+ pump has demonstrated that smooth muscle expresses the same gene (SERCA2) as slow skeletal muscle, cardiac muscle and non-muscle tissues [7] [8] [9] . However, alternative processing of the SERCA2 primary gene transcript results in three different SERCA2-derived mRNAs in pig smooth muscle [13] . Class 1 mRNA encodes the SERCA2a Ca2+ pump isoform (Mr 110000; 997 aa) whereas class 2 and 3 mRNAs encode the SERCA2b Ca2+ pump isoform (Mr 1 15 000; 1042 aa). The SERCA2a and SERCA2b isoforms differ only in their Ctermini: the SERCA2a C-terminus (-NYLEP/AILE) is replaced by an extended tail of 49 amino acids in the SERCA2b protein (-NYLEP/GKEC..4Iaa..MFWS) [5] [6] [7] . The SERCA2a isoform corresponds to the Ca2+ pump in slow skeletal and cardiac SR. The SERCA2b isoform represents a Ca2+ pump which is also found in non-muscle tissues such as liver, kidney and brain [5] [6] [7] [9] [10] [11] [12] [13] and which corresponds to the Ca2+ pump of the intracellular Ca2+ store in smooth muscle and non-muscle tissues. Whether this Ca2+ store is part of the ER or whether it is located in a distinct intracellular organelle is, however, still a matter of uncertainty.
A second component of the Ca2+-uptake system in slow skeletal and cardiac SR is phospholamban (PLB), a homopentameric phosphorylatable protein which functions as a regulatory protein of the SR Ca2+ pump. Dephosphorylated PLB inhibits the SR Ca2+ pump, but phosphorylation of PLB by cyclic AMP-, cyclic GMP-or Ca2+/calmodulin-dependent protein kinases alleviates this inhibition [14, 15] . A direct interaction between PLB and the SR CA2+ pump (SERCA2a and SERCAI isoforms), which depends on the phosphorylation status of PLB, has recently been demonstrated [16] . PLB has also been demonstrated in some smooth-muscle tissues, and the molecular cloning of smooth-muscle PLB has revealed that it is identical to the cardiac protein [17] [18] [19] [20] .
We have now analysed further the expression of the SERCA2 isoforms and of PLB in pig smooth muscle. mRNA levels were determined by means of an RNAase protection assay using a panel of anti-sense RNA probes. The expression of the SR/ER Ca2+-pump isoforms was also investigated on Western blots by means of isoform-specific antibodies. This study shows that the SERCA2 gene is expressed similarly in different smooth-muscle tissues and that the SERCA2b isoform is the predominant ER Ca2+ pump in smooth muscle. In contrast, PLB levels differ markedly between smooth-muscle tissues. PLB expression is therefore not coupled to the expression of SERCA2 in pig smooth muscle.
MATERIALS AND METHODS

RNA isolation
Pig gastric smooth muscle (antral part) was prepared by selectively removing the gastric serosa and mucosa from the antrum. Pig ileal longitudinal smooth muscle was obtained by selectively stripping the outer longitudinal smooth-muscle layer from the rest of the ileum. Pig aorta and pulmonary artery were prepared by removing the adventitia. The tissues were frozen in liquid N2 and stored at -80°C until used. The total RNA of the pig ileal and gastric smooth-muscle layer and of pig aorta, pulmonary artery, liver and heart were prepared according to the Chirgwin procedure [21] .
Abbreviations used: SR, sarcoplasmic reticulum; ER, endoplasmic reticulum; SERCA, sarcoplasmic/endoplasmic-reticulum Ca2l pump; PLB, phospholamban; aa, amino acid(s), nt, nucleotide(s).
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RNAase protection assay mRNA levels were semi-quantitatively determined according to the method of Lee & Costlow [22] . [7] ; pSERCA2b: XbaI-ScaI (nt 3250-3611) of pig SERCA2 class 2 cDNA [7] ; pPLB: DraI-EcoRI (nucleotides 551-737) of the pig PLB cDNA clone 8 [18] . Anti-sense RNA probes were synthesized by a transcription reaction in vitro by using a standard protocol [23] , except that 240 ,uCi of [a-32P]CTP (800 Ci/mmol; 40 mCi/ml) per transcription reaction was used and that the total concentration of CTP was adjusted to 20/tM with unlabelled CTP. SP6 RNA polymerase was used to synthesize pSERCA2b. T7 RNA polymerase was used for pSERCA2 and pPLB synthesis. After digestion with DNAase the probes were purified using a Sephadex G-50 spun column procedure [24] . RNA probes were labelled up to 106 c.p.m./ng of RNA. The integrity of the anti-sense RNA probes was checked on a 60% polyacrylamide/urea gel (more than 95 % full-length RNA) and their specificity was evaluated by Northern blot analysis (see ref. [13] )
Preparation of microsomes
Pig cardiac SR microsomes were prepared according to Jones & Cala [25] . Pig smooth-muscle ER microsomes of the stomach (antral part), pulmonary artery and aorta were prepared according to Raeymaekers et al. [26] . Pig liver microsomes were obtained as described by Gaetani et al. [27] .
Western blotting
The microsomal fractions of pig cardiac muscle, antrum, pulmonary artery, aorta and liver were separated on a Laemmli- [28] type polyacrylamide gel [7.5 % (w/w) acrylamide for SERCA2 detection or 15.0% (w/w) acrylamide for PLB detection], blotted on to Immobilon-P transfer membranes (Millipore Corp., Bedford, MA, U.S.A.) and immunostained as described previously [29] . The antisera, which were elicited against a peptide-BSA conjugate, were incubated for 1 h with 0.1 % (w/v) BSA in 150 mM-NaCl/10 mM-Tris/HCI, pH 7.5, to neutralize the anti-BSA antibodies, and were subsequently added to the blot.
Antibodies
The following antibodies were used to detect the SERCA2 isoforms and PLB. The monoclonal antibody recognizing SERCA2a and SERCA2b isoforms and the monoclonal antibody against PLB were kindly provided by Dr. K. P. Campbell (Howard Hughes Medical Institute, University of Iowa, Iowa City, IA, U.S.A.) and Dr. L. R. Jones (Krannert Institute of Cardiology, Indianapolis, IN, U.S.A.) respectively. The SERCA2b-specific polyclonal antiserum was elicited against the isoform-specific C-terminus of SERCA2b and has been described previously [30] .
A SERCA2a-specific polyclonal antiserum was obtained by immunizing rabbits with a BSA-coupled peptide (PEP2a: NYLEPAILE) that corresponds to the nine C-terminal amino acids of the pig SERCA2a isoform (aa 989-997) [7] . Glutaraldehyde-mediated coupling of PEP2a to BSA and immunization of rabbits were performed using a previously described protocol [30] . (Fig. lb) . Therefore the anti-PEP2a 2 . mRNA levels of SERCA2 and PLB and the ratio of PLB to SERCA2 mRNA levels in pig cardiac muscle, in pig smooth muscle of longitudinal ileum, antrum, pulmonary artery (PA), aorta and in pig liver were determined with an RNAase protection assay. a, SERCA2 mRNA levels determined with a non-discriminating antisense RNA probe (pSERCA2); *, PLB mRNA levels; i, ratio of PLB mRNA to SERCA2 mRNA. The SERCA2 and PLB bars correspond to mean mRNA levels (n = 5; S.E.M. indicated by the vertical line) which are expressed in 10-18 mol (amol) of transcripts/,ug of total RNA, except for the cardiac mRNA levels, for which the scale has been compressed 10-fold (values in parentheses apply to the cardiac mRNA levels). The PLB/SERCA2 ratio is expressed on a relative scale.
antiserum is specific for the SERCA2a isoform of the SR/ER Ca2+ pump.
Expression of the SERCA2 isoforms in smooth muscle
We have analysed the expression of SERCA2 in four different pig smooth-muscle tissues (longitudinal ileum, antrum, pulmonary artery and aorta) as well as in pig cardiac muscle and pig liver. The mRNA levels were first semi-quantitatively determined by means of an RNAase protection assay (see the Materials and methods section). To compare the SERCA2 mRNA levels we used an anti-sense RNA probe (pSERCA2) which corresponded to the common part of the SERCA2 transcripts (nt 1519-2027 [7] ) and which therefore did not discriminate between the different SERCA2-derived mRNAs. SERCA2iiJ]NAs were expressed at comparable levels in the four smooth-tniscle tissues and in liver ( Fig. 2) (Fig. 3) . Consequently, only 19 smooth-muscle SERCA2 mRNAs should code for the SERCA2a isoform. A direct assessment of the class 1 mRNA level was not possible, however, as any probe for the SERCA2a-specific part also reacts with the class 3 mRNAs. Similar conclusions based on S1 nuclease mapping experiments were drawn for rabbit and rat smooth muscle, although in some rat smooth-muscle tissues the SERCA2a mRNA accounted for up to 70 % of the total SERCA2 mRNA [8, 10] .
These data were complemented at the protein level. SERCA2 Ca2+ pumps were revealed on Western blots using the nondiscriminating anti-SERCA2 monoclonal antibody or polyclonal antisera specific for either the SERCA2a isoform or the SERCA2b isoform. When a Western blot containing SR-or ERenriched microsomes of cardiac muscle, antrum, pulmonary artery, aorta or liver was probed with the non-discriminating monoclonal antibody, an immunoreactive band of M, 100000 was detected in all tissues (Fig. 4a) . However, a different picture was obtained when the isoform-specific antisera were used. The SERCA2a isoform was clearly present in cardiac muscle and to a lesser extent in the smooth-muscle tissues, but it could not be detected in liver. The SERCA2b isoform was present in liver and smooth muscle, but it could not be detected in cardiac muscle (Fig. 4a) . The relative proportions of the SERCA2a and SERCA2b isoforms in smooth muscle were estimated by comparing the intensities of the SERCA2a and SERCA2b signals in smooth muscle with those in cardiac muscle and liver. When approximately equal amounts of the SERCA2 proteins were applied (as judged by the immunoreaction with the non-discriminating antibody), the SERCA2b signal in smooth muscle was comparable with that in liver, whereas the SERCA2a signal in smooth muscle was much less intense than that in cardiac muscle (Fig. 4a) . Therefore the SERCA2b isoform constitutes the majority of the ER Ca2+ pumps in smooth muscle.
Expression of PLB in smooth muscle
We next examined the expression of PLB in smooth muscle. PLB mRNA levels were determined by the RNAase protection assay. In contrast with the SERCA2 levels, PLB mRNA levels clearly differed between the smooth-muscle tissues, with a 12-fold difference between longitudinal ileum and aorta [(5 [7, 13] . Semi-quantitative analysis of the SERCA2 mRNA levels by means of an RNAase protection assay shows that the SERCA2 gene is expressed to a similar extent in four different smoothmuscle tissues and in liver. However, when compared with cardiac muscle, the SERCA2 mRNA levels in smooth muscle are 10-20-fold lower. In pig smooth muscle, 72 % (aorta) to 81 % (longitudinal ileum) of the SERCA2 mRNAs encode the SERCA2b isoform. Analysis of smooth-muscle membrane fractions with isoform-specific polyclonal antisera confirms that the SERCA2b isoform is the predominant Ca2+ pump in smooth muscle, whereas it cannot be detected in cardiac muscle. Therefore SERCA2 expression in different smooth-muscle tissues is fairly similar, but it differs both quantitatively (a 10-20-fold difference in mRNA level) and qualitatively (alternative processing ofthe SERCA2 transcripts leading to either the SERCA2a or the SERCA2b isoform) from that in cardiac muscle.
In contrast with SERCA2 expression, the expression of PLB varies markedly between different pig smooth-muscle tissues (longitudinal ileum > antrum > pulmonary artery > aorta). In the pig aorta, the mRNA level for PLB is very low, and PLB cannot be detected by immunostaining. However, in canine and bovine aorta and in bovine pulmonary artery, PLB can be readily detected either via immunostaining or via cyclic AMP-dependent phosphorylation [17, 18] Therefore PLB expression in the aorta and pulmonary artery seems to vary in a species-dependent way. Whether the low PLB/SERCA2 ratio in the pig arterial smooth muscle tissues has any functional implication still remains to be shown. As the cyclic AMP-or cyclic GMP-dependent regulation of the SR/ER Ca2+ uptake can be at least partially mediated via the phosphorylation of PLB [14, 15] , one might expect that the ER Ca2+ uptake in smooth-muscle tissues with a low PLB level is relatively insensitive to modulation by catecholamines, endothelium-derived relaxation factor and organic nitro-compounds. One should, however, bear in mind that the predominant Ca2+ pump in pig smooth muscle is the SERCA2b isoform, and that up until now no experimental data on SERCA2b regulation by PLB have been published. Therefore the impact of the various PLB levels on ER Ca2+ uptake in pig smooth muscle cannot be adequately assessed as long as the sensitivity of the SERCA2b protein for phospholamban has not been established.
In view of the co-expression of SERCA2a and PLB in slow skeletal and cardiac muscle [3, 31] and of the direct interaction between SERCA2a and PLB [16] , one might expect a coupling between the expression of PLB and that of SERCA2a. Indeed, parallel changes in SERCA2a and PLB mRNA levels have been observed in cardiac muscle during arterial pressure overload [32] and in skeletal muscle during chronic low-frequency stimulation [33] . However, experimentally induced hyperthyroidism increases the SERCA2a mRNA levels in cardiac muscle but down-regulates PLB mRNA [32] . Likewise, the PLB content of the four smoothmuscle tissues differs markedly, in spite of the similar SERCA2a levels. Therefore, although PLB and SERCA2a are co-ordinately expressed in some circumstances, their expression is not strictly coupled.
